Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Parkinson's Disease (GIPD)
NCT03659682Phase 2Unknown
- Sponsor
- Oslo University Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2024
01
Overview
A Phase 2 trial of semaglutide in Parkinson's disease (PD), sponsored by Oslo University Hospital. Status: unknown.
02
Drugs
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03659682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659682.